RXRX
insider transactionsRECURSION PHARMACEUTICALS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-2.9M
0 buy · 2.9M sell
Net value · 365d
-$12.9M
$0 in · $12.9M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
37
0 buy · 2.9M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$17.0K
5.4K sh · $3.15
Own -0%
-
Sell·S
Khan Najat KEY
CEO and President · 10b5-1
$84.5K
23.6K sh · $3.58
Own -1%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Sell·S
Director · 10b5-1
$144.8K
40.0K sh · $3.62
Own -4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +5%
-
Sell·S
Director · 10b5-1
$15.5K
4.4K sh · $3.54
Own -9%
-
Sell·S
Director · 10b5-1
$110.4K
30.0K sh · $3.68
Own -0%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Sell·S
Director · 10b5-1
$123.2K
40.0K sh · $3.08
Own -4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +5%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$76.1K
25.0K sh · $3.04
Own -2%
-
Other·F
Khan Najat KEY
CEO and President
$190.6K
62.7K sh · $3.04
Own -3%
-
Other·F
Chief Scientific Officer
$81.0K
26.7K sh · $3.04
Own -2%
-
Other·F
Director
$69.4K
22.8K sh · $3.04
Own -3%
-
Exercise·C
Director · 10b5-1
$0
60.0K sh
Own +1%
-
Other·G
Director · 10b5-1
$0
20.0K sh
Own -2%
-
Sell·S
Director · 10b5-1
$134.8K
40.0K sh · $3.37
Own -4%
-
Exercise·C
Director · 10b5-1
$0
60.0K sh
Own +7%
-
Sell·S
Director · 10b5-1
$105.6K
30.0K sh · $3.52
Own -0%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Sell·S
Director · 10b5-1
$144.4K
40.0K sh · $3.61
Own -4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Sell·S
Director · 10b5-1
$124.0K
40.0K sh · $3.10
Own -4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Director · 10b5-1
$93.0K
30.0K sh · $3.10
Own -0%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$149.4K
48.0K sh · $3.11
Own -4%
-
Grant·A
Director
$0
3.3K sh
Own +0%
-
Grant·A
Director
$0
4.9K sh
Own +3%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Director · 10b5-1
$130.0K
40.0K sh · $3.25
Own -4%
-
Sell·S
Taylor Ben R KEY
Chief Financial Officer · 10b5-1
$27.0K
8.0K sh · $3.39
Own -1%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer · 10b5-1
$24.2K
7.1K sh · $3.42
Own -1%
-
Exercise·C
Director · 10b5-1
$0
20.0K sh
Own +0%
-
Other·G
Director · 10b5-1
$0
20.0K sh
Own -2%
-
Exercise·C
Director · 10b5-1
$0
20.0K sh
Own +2%
-
Sell·S
Khan Najat KEY
CEO and President · 10b5-1
$94.8K
28.3K sh · $3.35
Own -1%
-
Sell·S
Director · 10b5-1
$588.2K
170.0K sh · $3.46
Own -3%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Director · 10b5-1
$138.4K
40.0K sh · $3.46
Own -4%
-
Sell·S
Taylor Ben R KEY
Chief Financial Officer · 10b5-1
$41.4K
13.4K sh · $3.08
Own -1%
-
Other·F
Khan Najat KEY
CEO and President
$49.8K
14.3K sh · $3.49
Own -1%
-
Other·F
Director · 10b5-1
$95.2K
27.3K sh · $3.49
Own -3%
-
Other·F
Chief Scientific Officer
$41.6K
11.9K sh · $3.49
Own -1%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer · 10b5-1
$41.6K
11.9K sh · $3.49
Own -1%
-
Other·F
Director · 10b5-1
$36.9K
10.4K sh · $3.56
Own -1%
-
Grant·A
Director · 10b5-1
$0
30.3K sh
Own +3%
-
Other·F
Khan Najat KEY
CEO and President
$41.2K
10.4K sh · $3.98
Own -0%
-
Grant·A
Khan Najat KEY
CEO and President
$0
1.7M sh
Own +274%
-
Grant·A
Khan Najat KEY
CEO and President
$0
30.3K sh
Own +1%
-
Other·F
Chief Scientific Officer
$45.4K
11.4K sh · $3.98
Own -1%
-
Grant·A
Chief Scientific Officer
$0
502.1K sh
Own +85%
-
Grant·A
Chief Scientific Officer
$0
24.3K sh
Own +2%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$45.4K
11.4K sh · $3.98
Own -1%
-
Grant·A
Taylor Ben R KEY
Chief Financial Officer
$0
24.3K sh
Own +2%
-
Grant·A
Taylor Ben R KEY
Chief Financial Officer
$0
446.3K sh
Own +59%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Director · 10b5-1
$164.8K
40.0K sh · $4.12
Own -4%
-
Sell·S
Director · 10b5-1
$924.0K
220.0K sh · $4.20
Own -3%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +1%
-
Sell·S
Director · 10b5-1
$178.8K
40.0K sh · $4.47
Own -4%
-
Exercise·C
Director · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Director · 10b5-1
$959.2K
220.0K sh · $4.36
Own -3%
-
Exercise·C
Director · 10b5-1
$0
60.0K sh
Own +1%
-
Other·G
Director · 10b5-1
$0
20.0K sh
Own -2%
-
Exercise·C
Director · 10b5-1
$0
60.0K sh
Own +7%
-
Sell·S
Director · 10b5-1
$170.0K
40.0K sh · $4.25
Own -4%
-
Grant·A
Director
$0
2.4K sh
Own +0%
-
Grant·A
Director
$0
3.6K sh
Own +3%
-
Sell·S
Taylor Ben R KEY
Chief Financial Officer · 10b5-1
$89.4K
21.4K sh · $4.18
Own -3%
-
Sell·S
Chief R&D Commercial Officer · 10b5-1
$548.6K
124.4K sh · $4.41
Own -17%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
40.0K sh
Own +1%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Chief Executive Officer · 10b5-1
$180.0K
40.0K sh · $4.50
Own -4%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$30.6K
7.1K sh · $4.33
Own -1%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
60.0K sh
Own +1%
-
Sell·S
Chief Executive Officer · 10b5-1
$185.2K
40.0K sh · $4.63
Own -4%
-
Other·G
Chief Executive Officer · 10b5-1
$0
20.0K sh
Own -2%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
60.0K sh
Own +7%
-
Sell·S
Director · 10b5-1
$961.4K
220.0K sh · $4.37
Own -3%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$9.2K
2.3K sh · $4.03
Own -0%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
40.0K sh
Own +1%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
40.0K sh
Own +4%
-
Sell·S
Chief Executive Officer · 10b5-1
$166.4K
40.0K sh · $4.16
Own -4%
-
Other·F
Chief R&D Commercial Officer
$72.8K
17.6K sh · $4.14
Own -2%
-
Other·F
Chief Executive Officer · 10b5-1
$167.2K
40.4K sh · $4.14
Own -4%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$49.3K
11.9K sh · $4.14
Own -1%
-
Grant·A
Chief R&D Commercial Officer
$0
169.9K sh
Own New
-
Grant·A
Chief R&D Commercial Officer
$0
84.9K sh
Own +13%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
60.0K sh
Own +1%
-
Other·G
Chief Executive Officer · 10b5-1
$0
20.0K sh
Own -2%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
60.0K sh
Own +6%
-
Sell·S
Chief Executive Officer · 10b5-1
$208.4K
40.0K sh · $5.21
Own -4%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +2%
-
Sell·S
Chief Executive Officer · 10b5-1
$570.0K
100.0K sh · $5.70
Own -9%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +10%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
120.0K sh
Own +2%
-
Sell·S
Chief Executive Officer · 10b5-1
$604.0K
100.0K sh · $6.04
Own -9%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
120.0K sh
Own +13%
-
Other·G
Chief Executive Officer · 10b5-1
$0
20.0K sh
Own -2%
-
Grant·A
Director
$0
2.9K sh
Own +2%
-
Grant·A
Director
$0
2.0K sh
Own +0%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
0 sh
Own +0%
-
Sell·S
Chief Executive Officer · 10b5-1
$476.0K
100.0K sh · $4.76
Own -9%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +10%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$34.1K
7.1K sh · $4.83
Own -1%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
120.0K sh
Own +2%
-
Sell·S
Chief Executive Officer · 10b5-1
$471.0K
100.0K sh · $4.71
Own -9%
-
Other·G
Chief Executive Officer · 10b5-1
$0
20.0K sh
Own -2%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
120.0K sh
Own +13%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +2%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +10%
-
Sell·S
Chief Executive Officer · 10b5-1
$484.0K
100.0K sh · $4.84
Own -9%
-
Sell·S
Chief R&D Commercial Officer
$202.0K
36.6K sh · $5.52
Own -5%
-
Other·F
Chief R&D Commercial Officer
$21.4K
3.8K sh · $5.64
Own -1%
-
Other·F
Taylor Ben R KEY
Chief Financial Officer
$67.2K
11.9K sh · $5.64
Own -1%
-
Other·F
Chief Executive Officer
$227.8K
40.4K sh · $5.64
Own -4%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
423.7K sh
Own +8%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own +35%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
17.9K sh
Own +56%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
17.9K sh
Own New
-
Sell·S
Chief Executive Officer · 10b5-1
$528.0K
100.0K sh · $5.28
Own -100%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
100.0K sh
Own New
-
Sell·S
Chief Executive Officer · 10b5-1
$94.4K
17.9K sh · $5.28
Own -100%
-
Other·G
Chief Executive Officer · 10b5-1
$0
10.0K sh
Own -1%
-
Sell·S
Chief Executive Officer · 10b5-1
$2.6M
500.3K sh · $5.28
Own -33%
-
Exercise·C
Chief Executive Officer · 10b5-1
$0
423.7K sh
Own +39%
-
Grant·A
Director
$0
2.9K sh
Own +2%
-
Grant·A
Director
$0
1.9K sh
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Taylor Ben R KEY | Other F | 5.4K | $17.0K |
| Jun 5, 2026 | Khan Najat KEY 10b5-1 | Sell S | 23.6K | $84.5K |
| Jun 5, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Jun 5, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $144.8K |
| Jun 5, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Jun 3, 2026 | Bumpus Namandje 10b5-1 | Sell S | 4.4K | $15.5K |
| Jun 2, 2026 | Borgeson Blake 10b5-1 | Sell S | 30.0K | $110.4K |
| May 22, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| May 22, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $123.2K |
| May 22, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| May 15, 2026 | Taylor Ben R KEY | Other F | 25.0K | $76.1K |
| May 15, 2026 | Khan Najat KEY | Other F | 62.7K | $190.6K |
| May 15, 2026 | Hallett David | Other F | 26.7K | $81.0K |
| May 15, 2026 | Gibson Christopher | Other F | 22.8K | $69.4K |
| May 7, 2026 | Gibson Christopher 10b5-1 | Exercise C | 60.0K | $0 |
| May 7, 2026 | Gibson Christopher 10b5-1 | Other G | 20.0K | $0 |
| May 7, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $134.8K |
| May 7, 2026 | Gibson Christopher 10b5-1 | Exercise C | 60.0K | $0 |
| May 5, 2026 | Borgeson Blake 10b5-1 | Sell S | 30.0K | $105.6K |
| Apr 22, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Apr 22, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $144.4K |
| Apr 22, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Apr 7, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Apr 7, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $124.0K |
| Apr 7, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Apr 7, 2026 | Borgeson Blake 10b5-1 | Sell S | 30.0K | $93.0K |
| Apr 6, 2026 | Taylor Ben R KEY | Other F | 48.0K | $149.4K |
| Apr 1, 2026 | Li Dean Y | Grant A | 3.3K | $0 |
| Apr 1, 2026 | Dar Zavain | Grant A | 4.9K | $0 |
| Mar 23, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Mar 23, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Mar 23, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $130.0K |
| Mar 17, 2026 | Taylor Ben R KEY 10b5-1 | Sell S | 8.0K | $27.0K |
| Mar 16, 2026 | Taylor Ben R KEY 10b5-1 | Other F | 7.1K | $24.2K |
| Mar 9, 2026 | Gibson Christopher 10b5-1 | Exercise C | 20.0K | $0 |
| Mar 9, 2026 | Gibson Christopher 10b5-1 | Other G | 20.0K | $0 |
| Mar 9, 2026 | Gibson Christopher 10b5-1 | Exercise C | 20.0K | $0 |
| Mar 9, 2026 | Khan Najat KEY 10b5-1 | Sell S | 28.3K | $94.8K |
| Mar 3, 2026 | Borgeson Blake 10b5-1 | Sell S | 170.0K | $588.2K |
| Feb 19, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Feb 19, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Feb 19, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $138.4K |
| Feb 18, 2026 | Taylor Ben R KEY 10b5-1 | Sell S | 13.4K | $41.4K |
| Feb 17, 2026 | Khan Najat KEY | Other F | 14.3K | $49.8K |
| Feb 17, 2026 | Gibson Christopher 10b5-1 | Other F | 27.3K | $95.2K |
| Feb 17, 2026 | Hallett David | Other F | 11.9K | $41.6K |
| Feb 17, 2026 | Taylor Ben R KEY 10b5-1 | Other F | 11.9K | $41.6K |
| Feb 6, 2026 | Gibson Christopher 10b5-1 | Other F | 10.4K | $36.9K |
| Feb 6, 2026 | Gibson Christopher 10b5-1 | Grant A | 30.3K | $0 |
| Feb 6, 2026 | Khan Najat KEY | Other F | 10.4K | $41.2K |
| Feb 6, 2026 | Khan Najat KEY | Grant A | 1.7M | $0 |
| Feb 6, 2026 | Khan Najat KEY | Grant A | 30.3K | $0 |
| Feb 6, 2026 | Hallett David | Other F | 11.4K | $45.4K |
| Feb 6, 2026 | Hallett David | Grant A | 502.1K | $0 |
| Feb 6, 2026 | Hallett David | Grant A | 24.3K | $0 |
| Feb 6, 2026 | Taylor Ben R KEY | Other F | 11.4K | $45.4K |
| Feb 6, 2026 | Taylor Ben R KEY | Grant A | 24.3K | $0 |
| Feb 6, 2026 | Taylor Ben R KEY | Grant A | 446.3K | $0 |
| Feb 4, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Feb 4, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Feb 4, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $164.8K |
| Feb 3, 2026 | Borgeson Blake 10b5-1 | Sell S | 220.0K | $924.0K |
| Jan 20, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Jan 20, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $178.8K |
| Jan 20, 2026 | Gibson Christopher 10b5-1 | Exercise C | 40.0K | $0 |
| Jan 6, 2026 | Borgeson Blake 10b5-1 | Sell S | 220.0K | $959.2K |
| Jan 5, 2026 | Gibson Christopher 10b5-1 | Exercise C | 60.0K | $0 |
| Jan 5, 2026 | Gibson Christopher 10b5-1 | Other G | 20.0K | $0 |
| Jan 5, 2026 | Gibson Christopher 10b5-1 | Exercise C | 60.0K | $0 |
| Jan 5, 2026 | Gibson Christopher 10b5-1 | Sell S | 40.0K | $170.0K |
| Jan 2, 2026 | Li Dean Y | Grant A | 2.4K | $0 |
| Jan 2, 2026 | Dar Zavain | Grant A | 3.6K | $0 |
| Dec 29, 2025 | Taylor Ben R KEY 10b5-1 | Sell S | 21.4K | $89.4K |
| Dec 22, 2025 | Khan Najat 10b5-1 | Sell S | 124.4K | $548.6K |
| Dec 19, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 40.0K | $0 |
| Dec 19, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 40.0K | $0 |
| Dec 19, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 40.0K | $180.0K |
| Dec 15, 2025 | Taylor Ben R KEY | Other F | 7.1K | $30.6K |
| Dec 4, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 60.0K | $0 |
| Dec 4, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 40.0K | $185.2K |
| Dec 4, 2025 | Gibson Christopher KEY 10b5-1 | Other G | 20.0K | $0 |
| Dec 4, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 60.0K | $0 |
| Dec 2, 2025 | Borgeson Blake 10b5-1 | Sell S | 220.0K | $961.4K |
| Nov 25, 2025 | Taylor Ben R KEY | Other F | 2.3K | $9.2K |
| Nov 19, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 40.0K | $0 |
| Nov 19, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 40.0K | $0 |
| Nov 19, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 40.0K | $166.4K |
| Nov 17, 2025 | Khan Najat | Other F | 17.6K | $72.8K |
| Nov 17, 2025 | Gibson Christopher KEY 10b5-1 | Other F | 40.4K | $167.2K |
| Nov 17, 2025 | Taylor Ben R KEY | Other F | 11.9K | $49.3K |
| Nov 5, 2025 | Khan Najat | Grant A | 169.9K | $0 |
| Nov 5, 2025 | Khan Najat | Grant A | 84.9K | $0 |
| Nov 4, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 60.0K | $0 |
| Nov 4, 2025 | Gibson Christopher KEY 10b5-1 | Other G | 20.0K | $0 |
| Nov 4, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 60.0K | $0 |
| Nov 4, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 40.0K | $208.4K |
| Oct 23, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Oct 23, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $570.0K |
| Oct 23, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Oct 10, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 120.0K | $0 |
| Oct 10, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $604.0K |
| Oct 10, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 120.0K | $0 |
| Oct 10, 2025 | Gibson Christopher KEY 10b5-1 | Other G | 20.0K | $0 |
| Oct 1, 2025 | Dar Zavain | Grant A | 2.9K | $0 |
| Oct 1, 2025 | Li Dean Y | Grant A | 2.0K | $0 |
| Sep 25, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 0 | $0 |
| Sep 25, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $476.0K |
| Sep 25, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Sep 15, 2025 | Taylor Ben R KEY | Other F | 7.1K | $34.1K |
| Sep 10, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 120.0K | $0 |
| Sep 10, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $471.0K |
| Sep 10, 2025 | Gibson Christopher KEY 10b5-1 | Other G | 20.0K | $0 |
| Sep 10, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 120.0K | $0 |
| Aug 26, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Aug 26, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Aug 26, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $484.0K |
| Aug 18, 2025 | Khan Najat | Sell S | 36.6K | $202.0K |
| Aug 15, 2025 | Khan Najat | Other F | 3.8K | $21.4K |
| Aug 15, 2025 | Taylor Ben R KEY | Other F | 11.9K | $67.2K |
| Aug 15, 2025 | Gibson Christopher KEY | Other F | 40.4K | $227.8K |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 423.7K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 17.9K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 17.9K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 100.0K | $528.0K |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 100.0K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 17.9K | $94.4K |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Other G | 10.0K | $0 |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Sell S | 500.3K | $2.6M |
| Aug 11, 2025 | Gibson Christopher KEY 10b5-1 | Exercise C | 423.7K | $0 |
| Jul 1, 2025 | Dar Zavain | Grant A | 2.9K | $0 |
| Jul 1, 2025 | Li Dean Y | Grant A | 1.9K | $0 |
About RXRX insider trading
This page tracks insider transactions for RECURSION PHARMACEUTICALS, INC. (RXRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.